Magnesium sulfate treatment decreases the initial brain damage alterations produced after perinatal asphyxia in fetal lambs

Journal of Neuroscience Research

Volumn 90, Issue 10, 2012, Pages 1932-1940

  Goñi de Cerio, Felipe ^a   Alvarez, Antonia ^a   Lara Celador, Idoia ^a   Alvarez, Francisco J ^b   Alonso Alconada, Daniel ^a   Hilario, Enrique ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

Brain damage; Cell death; Hypoxic ischemic injury; Lamb; Magnesium sulfate

Indexed keywords

CALCIUM ION; MAGNESIUM SULFATE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ARTIFICIAL VENTILATION; BASAL AMYGDALA; BRAIN CORTEX; BRAIN DAMAGE; BRAIN MITOCHONDRION; CALCIUM CELL LEVEL; CELL MEMBRANE; CELL VIABILITY; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FETUS; FLOW CYTOMETRY; HYPOTHALAMUS; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LAMB; MESENCEPHALON; MICROPHOTOGRAPHY; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL NECROSIS; NICK END LABELING; NONHUMAN; PERINATAL ASPHYXIA; PONS; PREMATURITY; PRIORITY JOURNAL; THALAMUS; UMBILICAL CORD;

ANIMALS; ANIMALS, NEWBORN; ANNEXIN A5; APOPTOSIS; ASPHYXIA; BRAIN DAMAGE, CHRONIC; CALCIUM; CAROTID ARTERIES; CELL MEMBRANE; FEMALE; FETUS; FLUORESCENT DYES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MAGNESIUM SULFATE; MEMBRANE POTENTIALS; MITOCHONDRIAL MEMBRANES; PREGNANCY; PRIMED IN SITU LABELING; REACTIVE OXYGEN SPECIES; RHODAMINE 123; SHEEP; SPINAL CORD;

EID: 84864846022     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23091     Document Type: Article

References (53)

1. Alison G, Cahill MD, Aaron B, Caughey MD. 2009. Magnesium for neuroprophylaxis: fact or fiction? Am J Obstet and Gynecol 200: 590-594.
2. Burd I, Breen K, Friedman A, Chai J, Elovitz MA. 2010. Magnesium sulfate reduces inflammation-associated brain injury in fetal mice. Am J Obstet Gynecol 202: 292.e1-292.e 9.
3. Calvert JW, Zhang JH. 2005. Pathophysiology of a hypoxic-ischemic insult during the perinatal period. Neurol Res 27: 246-260.
4. Cetinkaya M, Alkan T, Ozyener F, Kafa IM, Kurt MA, Koksal N. 2010. Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model. Neonatology 99: 302-310.
5. Charriaut-Marlangue C, Ben-Ari Y. 1995. A cautionary note on the use of TUNEL stain to determine apoptosis. Neuroreport 7: 61-62.
6. Costantine MM, Drever N. 2011. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants. Obstet Gynecol Clin North Am 38: 351-366.
7. Degos V, Loron G, Mantz J, Gressens P. 2008. Neuroprotective strategies for the neonatal brain. Anesthesia Analgesia 106: 1670-1680.
8. Dribben WH, Creeley CE, Wang HH, Smith DJ, Farber NB, Olney JW. 2009. High dose magnesium sulfate exposure induces apoptotic cell death in the developing neonatal mouse brain. Neonatology 96: 23-32.
9. Elliott JP, Lewis DF, Morrison JC, Garite TJ. 2009. In defense of magnesium sulfate. Obstet Gynecol 113: 341-1348.
10. Falkowski A, Hammond R, Han V, Richardson B. 2002. Apoptosis in the preterm and near term ovine fetal brain and the effect of intermittent umbilical cord occlusion. Brain Res Dev Brain Res 136: 165-173.
11. Fernandez-Gomez FJ, Galindo MF, Gomez-Lazaro M, González-García C, Ceña V, Aguirre N, Jordán J. 2005. Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions. 133: 959-967.
12. Gee JB2nd, Corbett RJ, Perlman J, Laptook AR. 2004. The effects of systemic magnesium sulfate infusion on brain magnesium concentrations and energy state during hypoxia-ischemia in newborn miniswine. Pediatr Res 55: 93-100.
13. Gerstein M, Huleihel M, Mane R, Stilman M, Kashtuzki I, Hallak M, Golan H. 2005. Remodeling of hippocampal GABAergic system in adult offspring after maternal hypoxia and magnesium sulfate load: immunohistochemical study. Exp Neurol 196: 18-29.
14. Goñi de Cerio F, Alvarez A, Caballero A, Mielgo VE, Alvarez FJ, Rey-Santano MC, Gastiasoro E, Valls-i-Soler A, Bilbao J, Hilario E. 2007. Early cell death in the brain of fetal preterm lambs after hypoxic-ischemic injury. Brain Res 1151: 161-171.
15. 4 treatment preserves the ischemia-induced reduction in S-100 protein without modification of the expression of endothelial tight junction molecules. Histol Histopathol 24: 1129-1138.
16. Greenwood K, Cox P, Mehmet H, Penrice J, Amess PN, Cady EB, Wyatt JS, Edwards AD. 2000. Magnesium sulfate treatment after transient hypoxia-ischemia in newborn piglet does not protect against cerebral damage. Pediatric Res 48: 346-350.
17. Grow J, Barks JD. 2002. Pathogenesis of hypoxic-ischemic cerebral injury in the term infant: current concepts. Clin Perinatol 29: 585-602.
18. Hamrick SE, Ferriero DM. 2003. The injury response in the term newborn brain: can we neuroprotect? Curr Opin Neurol 16: 147-154.
19. Hilario E, Rey MC, Goñi de Cerio F, Alvarez FJ, Caballero A, Gastiasoro E, Gomez-Urquijo S, Valls-i-Soler A, Alvarez A. 2005. Cerebral blood flow and morphological changes after hypoxic-ischemic injury in preterm lambs. Acta Paediatr 94: 903-911.
20. Hilario E, Alvarez A, Alvarez FJ, Gastiasoro E, Valls-i-Soler A. 2006. Cellular mechanisms in perinatal hypoxic-ischemic brain injury. Curr Pediatric Rev 2: 131-141.
21. 4 infusion on NMDA receptor binding characteristics during cerebral cortical hypoxia in the newborn piglet. Brain Res 644: 144-149.
22. Horn M, Schlote W. 1992. Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia. Acta Neuropathol 85: 79-87.
23. Ikeda T, Murata Y, Quilligan EJ, Choi BH, Parer JT, Doi S, Park SD. 1998. Physiologic and histologic changes in near-term fetal lambs exposed to asphyxia by partial umbilical cord occlusion. Am J Obstet Gynecol 178: 24-32.
24. Kalincik T, Maresova D. 2005. Influence of magnesium sulphate on evoked activity of rat brain after exposure to short-term hypoxia. Physiol Res 54: 229-234.
25. Kang SW, Choi SK, Park E, Chae SJ, Choi S, Jin Joo H, Lee GJ, Park HK. 2011. Neuroprotective effects of magnesium-sulfate on ischemic injury mediated by modulating the release of glutamate and reduced of hyperreperfusion. Brain Res 1371: 121-128.
26. Kaptanoglu E, Okutan O, Akbiyik F. 2004. Correlation of injury severity and tissue Evans blue content, lipid peroxidation and clinical evaluation in acute spinal cord injury rats. J Clin Neurosci 11: 879-885.
27. Khashaba MT, Shouman BO, Shaltout AA, Al-Marsafawy HM, Abdel-Aziz MM, Patel K, Aly H. 2006. Excitatory amino acids and magnesium sulfate in neonatal asphyxia. Brain Dev 28: 375-379.
28. Levene M, Evans D, Mason S, Brown J. 1999. An international network for evaluating neuroprotective therapy after severe birth asphyxia. Semin Perinatol 23: 226-233.
29. Mami AG, Ballesteros J, Mishra OP, Delivoria-Papadopoulos M. 2006. Effects of magnesium sulfate administration during hypoxia on Ca influx and IP receptor modification in cerebral cortical neuronal nuclei of newborn piglets. Neurochem Res 31: 63-70.
30. Marret S, Lex W, Doyle LW, Crowther CA, Middleton A. 2007. Antenatal magnesium sulphate neuroprotection in the preterm infant. Semin Fetal Neonatal Med 12: 311-317.
31. Nagdyman N, Kömen W, Ko HK, Müller C, Obladen M. 2001. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res 49: 502-506.
32. Ovbiagele B, Kidwell CS, Starkman S, Saver JL. 2003. Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep 3: 9-20.
33. 4. Neonatology 95: 33-40.
34. Perlman JM. 2006. Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clin Ther 28: 1353-1365.
35. Peruche B, Krieglstein J. 1993. Mechanisms of drug actions against neuronal damage caused by ischemia. Prog Neuropsychopharmacol Biol Psychiatry 17: 21-70.
36. Raju TNK. 1992. Some animal models for the study of perinatal asphyxia. Biol Neonate 62: 202-214.
37. Rouse DJ. 2009. Magnesium sulfate for the prevention of cerebral palsy. Am J Obstet Gynecol 200: 610-612.
38. Rouse DJ, Hirtz DG, Thom E. 2008. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 359: 895-905.
39. Solaroglu I, Kaptanoglu E, Okutan O, Beskonakli E, Attar A, Kilinc K. 2005. Magnesium sulfate treatment decreases caspase-3 activity alter experimental spinal cord injury in rats. Surg Neurol 64: 17-21.
40. Solaroglu A, Suat Dede F, Gelisen O, Secilmis O, Dede H. 2011. Neuroprotective effect of magnesium sulfate treatment on fetal brain in experimental intrauterine ischemia reperfusion injury. J Matern Fetal Neonatal Med 24: 1259-1261.
41. 4 administration after cerebral hypoxia-ischemia in newborn rats is related to the severity of brain damage. Reprod Sci 14: 667-677.
42. Sugawara T, Fujimura M, Noshita N, Kim GW, Saito A, Hayashi T, Narasimhan P, Maier CM, Chan PH. 2004. Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 1: 17-25.
43. Szemraj J, Sobolewska B, Gulczynska E, Wilczynski J, Zylinska L. 2005. Magnesium sulfate effect on erythrocyte membranes of asphyxiated newborns. Clin Biochem 38: 457-464.
44. Temkin N, Anderson GD, Winn HR, Ellenbogen RG, Britz GW, Schuster J, Lucas T, Newell DW, Mansfield PN, Machamer JE, Barber J, Dikmen SS. 2007. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 6: 29-38.
45. Turkyilmaz C, Turkyilmaz Z, Atalay Y, Soylemezoglu F, Celasen B. 2002. Magnesium pre-treatment reduces neuronal apoptosis in newborn rats in hypoxia-ischemia. Brain Res 955: 133-137.
46. Van Reempts JLH. 1984. The hypoxic brain: histological and ultrastructural aspects. Behav Brain Res 14: 99-108.
47. Volpe JJ. 2001. Hypoxic-ischemic encelopathy: clinical aspects. In: Volpe JJ, editor. Neurology of the newborn. Philadelphia: W.B. Saunders Co. p 331-394.
48. Volpe JJ. 2009a. Brain injury in premature infants: a complex almagam of destructive and developmental disturbances. Lancet Neurol 8: 110-124.
49. Volpe J. 2009b. Cerebellum of the premature infant: rapidly developing, vulnerable, clinically important. J Child Neurol 24: 1085-1104.
50. Westermaier T, Zausinger S, Baethmann A, Schmid-Elsaesser R. 2005. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats. Acta Neurochir 147: 525-532.
51. Yager JY. 2004. Animal models of hypoxic-ischemic brain damage in the newborn. Semin Pediatr Neurol 11: 31-46.
52. Zhu HD, Meloni BP, Moore SR, Majda BT, Knuckey NW. 2004. Intravenous administration of magnesium is only neuroprotective following transient global ischemia when present with post-ischemic mild hypothermia. Brain Res 1014: 53-60.
53. Zhu H, Meloni BP, Bojarski C, Knuckey MW, Knuckey NW. 2005. Post-ischemic modest hypothermia (35 degrees C) combined with intravenous magnesium is more effective at reducing CA1 neuronal death than either treatment used alone following global cerebral ischemia in rats. Exp Neurol 193: 361-368.